Article
Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia.
The Journal of molecular diagnostics : JMD - 1 Sept 2020
Lee Jimmy, Wang Y Lynn
Abstract excerpt
Chronic lymphocytic leukemia (CLL) is a malignancy of B cells with a variable clinical course. Prognostication is important to place patients into different risk categories for guiding decisions on clinical management, to treat or not to treat. Although several clinical, cytogenetic, and molecular parameters have been established, in the past decade, a tremendous understanding of molecular lesions has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
